{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:53Z","timestamp":1791843233356,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","award":["NRF-2018M3A9F3020956"],"award-info":[{"award-number":["NRF-2018M3A9F3020956"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","award":["NRF-2019R1I1A3A01060447"],"award-info":[{"award-number":["NRF-2019R1I1A3A01060447"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","award":["NRF-2020R1A6A1A03043026"],"award-info":[{"award-number":["NRF-2020R1A6A1A03043026"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["P0020622"],"award-info":[{"award-number":["P0020622"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12072-023-10518-9","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T07:07:28Z","timestamp":1680246448000},"page":"486-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease"],"prefix":"10.1007","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct04339725","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Raja","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haripriya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Priya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Min","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Kwang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hak","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Ho","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Seok","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-9245","authenticated-orcid":false,"given":"Ki Tae","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"2","key":"10518_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1055\/s-0029-1214372","volume":"29","author":"B Nath","year":"2009","unstructured":"Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis. 2009;29(2):166\u2013177","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10518_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.livres.2019.09.001","volume":"3","author":"F Li","year":"2019","unstructured":"Li F, McClain CJ, Feng W. Microbiome dysbiosis and alcoholic liver disease. Liver Res. 2019;3(3):218\u2013226","journal-title":"Liver Res"},{"issue":"1","key":"10518_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/ijms24010537","volume":"24","author":"R Ganesan","year":"2023","unstructured":"Ganesan R, Yoon SJ, Suk KT. Microbiome and metabolomics in liver cancer: scientific technology. Int J Mol Sci. 2023;24(1):537","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10518_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(4):235\u2013246","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10518_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/liv.14383","volume":"40","author":"G Addolorato","year":"2020","unstructured":"Addolorato G, et al. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease. Liver Int. 2020;40(4):878\u2013888","journal-title":"Liver Int"},{"issue":"5","key":"10518_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","volume":"32","author":"A Parlesak","year":"2000","unstructured":"Parlesak A, et al. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32(5):742\u2013747","journal-title":"J Hepatol"},{"issue":"3","key":"10518_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cld.2016.02.014","volume":"20","author":"C Chan","year":"2016","unstructured":"Chan C, Levitsky J. Infection and alcoholic liver disease. Clin Liver Dis. 2016;20(3):595\u2013606","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10518_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246\u20131256 (1256 e1\u20135)","journal-title":"Gastroenterology"},{"issue":"1","key":"10518_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina VB, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141","journal-title":"Microbiome"},{"issue":"11","key":"10518_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","volume":"27","author":"SH Han","year":"2015","unstructured":"Han SH, et al. Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol. 2015;27(11):1300\u20131306","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10518_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/tx700335d","volume":"21","author":"M Coen","year":"2008","unstructured":"Coen M, et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 2008;21(1):9\u201327","journal-title":"Chem Res Toxicol"},{"issue":"15","key":"10518_CR12","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.3390\/ijms23158749","volume":"23","author":"JY Hyun","year":"2022","unstructured":"Hyun JY, et al. Microbiome-based metabolic therapeutic approaches in alcoholic liver disease. Int J Mol Sci. 2022;23(15):8749","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10518_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/ijms22031160","volume":"22","author":"G Raja","year":"2021","unstructured":"Raja G, et al. Recent advances of microbiome-associated metabolomics profiling in liver disease: principles, mechanisms, and applications. Int J Mol Sci. 2021;22(3):1160","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10518_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3350\/cmh.2022.0171","volume":"28","author":"R Ganesan","year":"2022","unstructured":"Ganesan R, Suk KT. Microbiome and metabolomics in alcoholic liver disease. Clin Mol Hepatol. 2022;28(3):580\u2013582","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10518_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134(5):714\u2013717","journal-title":"Cell"},{"issue":"7","key":"10518_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/molecules22071173","volume":"22","author":"B Li","year":"2017","unstructured":"Li B, et al. Novel applications of metabolomics in personalized medicine: a mini-review. Molecules. 2017;22(7):1173","journal-title":"Molecules"},{"issue":"4","key":"10518_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1467-3010.2008.00733.x","volume":"33","author":"A Koulman","year":"2008","unstructured":"Koulman A, Volmer DA. Perspectives for metabolomics in human nutrition: an overview. Nutr Bull. 2008;33(4):324\u2013330","journal-title":"Nutr Bull"},{"issue":"6","key":"10518_CR18","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1073\/pnas.0712038105","volume":"105","author":"M Li","year":"2008","unstructured":"Li M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008;105(6):2117\u20132122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10518_CR19","doi-asserted-by":"publisher","first-page":"e00579","DOI":"10.1128\/mSystems.00579-19","volume":"4","author":"C Noecker","year":"2019","unstructured":"Noecker C, et al. Defining and evaluating microbial contributions to metabolite variation in microbiome-metabolome association studies. mSystems. 2019;4(6):e00579","journal-title":"mSystems"},{"issue":"8","key":"10518_CR20","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/acs.jproteome.9b00185","volume":"18","author":"A Ferrarini","year":"2019","unstructured":"Ferrarini A, et al. Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma. J Proteome Res. 2019;18(8):3067\u20133076","journal-title":"J Proteome Res"},{"issue":"2","key":"10518_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1021\/acsomega.0c04259","volume":"6","author":"HY Pan","year":"2021","unstructured":"Pan HY, et al. LC\/MS-based global metabolomic identification of serum biomarkers differentiating hepatocellular carcinoma from chronic hepatitis b and liver cirrhosis. ACS Omega. 2021;6(2):1160\u20131170","journal-title":"ACS Omega"},{"issue":"5","key":"10518_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","volume":"67","author":"SH Yoon","year":"2017","unstructured":"Yoon SH, et al. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int J Syst Evol Microbiol. 2017;67(5):1613\u20131617","journal-title":"Int J Syst Evol Microbiol"},{"issue":"19","key":"10518_CR23","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460\u20132461","journal-title":"Bioinformatics"},{"issue":"6","key":"10518_CR24","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60","journal-title":"Genome Biol"},{"key":"10518_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4939-8728-3_11","volume":"1849","author":"GM Douglas","year":"2018","unstructured":"Douglas GM, Beiko RG, Langille MGI. Predicting the functional potential of the microbiome from marker genes using PICRUSt. Methods Mol Biol. 2018;1849:169\u2013177","journal-title":"Methods Mol Biol"},{"key":"10518_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.aca.2014.11.015","volume":"854","author":"J Han","year":"2015","unstructured":"Han J, et al. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2015;854:86\u201394","journal-title":"Anal Chim Acta"},{"key":"10518_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.137267","volume":"718","author":"SJ Park","year":"2020","unstructured":"Park SJ, et al. Exposure of ultrafine particulate matter causes glutathione redox imbalance in the hippocampus: a neurometabolic susceptibility to Alzheimer\u2019s pathology. Sci Total Environ. 2020;718: 137267","journal-title":"Sci Total Environ"},{"key":"10518_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1712984","volume":"11","author":"NY Lee","year":"2020","unstructured":"Lee NY, et al. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes. 2020;11:1\u201318","journal-title":"Gut Microbes"},{"issue":"1","key":"10518_CR29","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1038\/s41598-018-27600-0","volume":"8","author":"DY Ji","year":"2018","unstructured":"Ji DY, et al. Comparative assessment of Graves\u2019 disease and main extrathyroidal manifestation, Graves\u2019 ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue. Sci Rep. 2018;8(1):9262","journal-title":"Sci Rep"},{"issue":"6","key":"10518_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cmet.2019.03.004","volume":"29","author":"AA Polyzos","year":"2019","unstructured":"Polyzos AA, et al. Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in huntington mice. Cell Metab. 2019;29(6):1258-1273.e11","journal-title":"Cell Metab"},{"issue":"4","key":"10518_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/19490976.2020.1712984","volume":"11","author":"NY Lee","year":"2020","unstructured":"Lee NY, et al. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes. 2020;11(4):882\u2013899","journal-title":"Gut Microbes"},{"issue":"W1","key":"10518_CR32","doi-asserted-by":"publisher","first-page":"W162","DOI":"10.1093\/nar\/gkx449","volume":"45","author":"B Li","year":"2017","unstructured":"Li B, et al. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Res. 2017;45(W1):W162\u2013W170","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10518_CR33","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","volume":"17","author":"Z Pang","year":"2022","unstructured":"Pang Z, et al. Using MetaboAnalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 2022;17(8):1735\u20131761","journal-title":"Nat Protoc"},{"issue":"10","key":"10518_CR34","first-page":"633","volume":"9","author":"J Guy","year":"2013","unstructured":"Guy J, Peters MG. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y). 2013;9(10):633\u2013639","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"9","key":"10518_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","volume":"51","author":"ZH Zhao","year":"2019","unstructured":"Zhao ZH, et al. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp Mol Med. 2019;51(9):1\u201314","journal-title":"Exp Mol Med"},{"key":"10518_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12986-018-0241-7","volume":"15","author":"B Bjorndal","year":"2018","unstructured":"Bjorndal B, et al. Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice. Nutr Metab (Lond). 2018;15:10","journal-title":"Nutr Metab (Lond)"},{"issue":"4 Pt B","key":"10518_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","volume":"1864","author":"T Vasavan","year":"2018","unstructured":"Vasavan T, et al. Heart and bile acids\u2014clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1345\u20131355","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"10518_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.27744","volume":"62","author":"NS Ghonem","year":"2015","unstructured":"Ghonem NS, Assis DN, Boyer JL. Fibrates and cholestasis. Hepatology. 2015;62(2):635\u2013643","journal-title":"Hepatology"},{"issue":"1","key":"10518_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053028","volume":"8","author":"L Bull-Otterson","year":"2013","unstructured":"Bull-Otterson L, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS ONE. 2013;8(1): e53028","journal-title":"PLoS ONE"},{"issue":"9","key":"10518_CR40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496\u2013503","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10518_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/AAC.00812-08","volume":"53","author":"HJ Warshakoon","year":"2009","unstructured":"Warshakoon HJ, Burns MR, David SA. Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides. Antimicrob Agents Chemother. 2009;53(1):57\u201362","journal-title":"Antimicrob Agents Chemother"},{"key":"10518_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2017.07.003","volume":"39","author":"Y Litvak","year":"2017","unstructured":"Litvak Y, et al. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017;39:1\u20136","journal-title":"Curr Opin Microbiol"},{"issue":"5","key":"10518_CR43","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","volume":"58","author":"EM Quigley","year":"2013","unstructured":"Quigley EM, Stanton C, Murphy EF. The gut microbiota and the liver Pathophysiological and clinical implications. J Hepatol. 2013;58(5):1020\u20131027","journal-title":"J Hepatol"},{"issue":"7","key":"10518_CR44","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.14309\/ajg.0000000000000102","volume":"114","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, et al. Specific gut and salivary microbiota patterns are linked with different cognitive testing strategies in minimal hepatic encephalopathy. Am J Gastroenterol. 2019;114(7):1080\u20131090","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10518_CR45","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940\u2013947","journal-title":"J Hepatol"},{"key":"10518_CR46","doi-asserted-by":"publisher","first-page":"34055","DOI":"10.1038\/srep34055","volume":"6","author":"Y Chen","year":"2016","unstructured":"Chen Y, et al. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep. 2016;6:34055","journal-title":"Sci Rep"},{"issue":"6","key":"10518_CR47","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/liv.14437","volume":"40","author":"JS Bajaj","year":"2020","unstructured":"Bajaj JS, et al. Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico. Liver Int. 2020;40(6):1395\u20131407","journal-title":"Liver Int"},{"issue":"6","key":"10518_CR48","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2014.01.052","volume":"146","author":"EB Hollister","year":"2014","unstructured":"Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology. 2014;146(6):1449\u20131458","journal-title":"Gastroenterology"},{"issue":"6","key":"10518_CR49","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 2012;303(6):G675\u2013G685","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10518_CR50","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ecco-jcc\/jjw070","volume":"10","author":"H Eppinga","year":"2016","unstructured":"Eppinga H, et al. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in Hidradenitis Suppurativa. J Crohns Colitis. 2016;10(9):1067\u20131075","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10518_CR51","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54(2):562\u2013572","journal-title":"Hepatology"},{"issue":"1","key":"10518_CR52","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","volume":"9","author":"SB Ahn","year":"2019","unstructured":"Ahn SB, et al. Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease. Sci Rep. 2019;9(1):5688","journal-title":"Sci Rep"},{"issue":"1","key":"10518_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","volume":"27","author":"B Seo","year":"2020","unstructured":"Seo B, et al. Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host Microbe. 2020;27(1):25-40.e6","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10518_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.livres.2019.02.001","volume":"3","author":"L Wang","year":"2019","unstructured":"Wang L, Wan Y-JY. The role of gut microbiota in liver disease development and treatment. Liver Res. 2019;3(1):3\u201318","journal-title":"Liver Res"},{"issue":"2","key":"10518_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/MMBR.00031-07","volume":"72","author":"AL Davidson","year":"2008","unstructured":"Davidson AL, et al. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev. 2008;72(2):317\u2013364","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10518_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1471-2180-12-248","volume":"12","author":"CJ Meehan","year":"2012","unstructured":"Meehan CJ, Beiko RG. Lateral gene transfer of an ABC transporter complex between major constituents of the human gut microbiome. BMC Microbiol. 2012;12(1):248","journal-title":"BMC Microbiol"},{"issue":"24","key":"10518_CR57","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1021\/acs.jafc.0c01947","volume":"68","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Gut Microbiome and metabolome response of Pu-erh Tea on metabolism disorder induced by chronic alcohol consumption. J Agric Food Chem. 2020;68(24):6615\u20136627","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10518_CR58","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.1038\/s41598-019-47216-2","volume":"9","author":"K Enooku","year":"2019","unstructured":"Enooku K, et al. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Sci Rep. 2019;9(1):10663","journal-title":"Sci Rep"},{"issue":"1","key":"10518_CR59","doi-asserted-by":"publisher","first-page":"10953","DOI":"10.1038\/s41598-018-29222-y","volume":"8","author":"S Jeyapal","year":"2018","unstructured":"Jeyapal S, et al. Substitution of linoleic acid with alpha-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. Sci Rep. 2018;8(1):10953","journal-title":"Sci Rep"},{"issue":"1","key":"10518_CR60","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1038\/s41598-020-63627-y","volume":"10","author":"S Sanada","year":"2020","unstructured":"Sanada S, et al. Intestinal microbial metabolite stercobilin involvement in the chronic inflammation of ob\/ob mice. Sci Rep. 2020;10(1):6479","journal-title":"Sci Rep"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10518-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10518-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10518-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T15:10:04Z","timestamp":1712934604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10518-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10518"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10518-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2408045\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"24 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts to declare (Raja Ganesan, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Sang Hak Han, Young Joo Yang, Gwang Ho Baik, Chang Seok Bang, Dong Joon Kim, Ki Tae Suk).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in conformance with the ethical guidelines from the 1975 Helsinki Declaration as it is reflected by a priori approval of the institutional review board for human research. Informed consent on enrollment was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval statement"}},{"value":"All subjects have written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}